Healthcare
0
Oracle’s CEO Talks About the Company’s Evolution into Healthcare
0

On Tuesday, October 29, Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, who served as administrator of CMS under ...

0
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
0

Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...

0
Merchants of Death – Healthcare Economist
0

That's the clever title of recient American Economic Review post by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, ...

0
Best practices for conducting a scoping review – Healthcare Economist
0

Scoping reviews are a type of knowledge synthesis, following a systematic approach to mapping the evidence on a topic and ...

0
Use of real-world data for measuring treatment effectiveness for target populations – Healthcare Economist
0

Randomized controlled trials are the gold standard for evaluating treatment effectiveness, but real-world effectiveness may vary. One reason for this is ...

0
‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist
0

That is the title of a KFF article published last week. Results are based on KFF. 2024 Employer Health Benefits Survey. ...

0
CMS Announces Coverage of Traditional Healthcare Practices
0

In a press release dated October 16, the US Department of Health and Human Services (HHS)through the Centers for Medicare and Medicaid Services (CMS)announced ...

0
What is microRNA and why did its discovery merit this year’s Nobel Prize for Medicine? – Healthcare Economist
0

This year the Nobel Prize in Medicine went to Victor Ambros, currently Professor of Natural Sciences at the University of ...

0
The new OMB Social Welfare Function – Healthcare Economist
0

Recently, the Office of Management and Budget has published new procedures for evaluating government regulation (Circular A-4) and economic policies ...

0
Why aren’t people using Paxlovid? – Healthcare Economist
0

Paxlovid (nirmatrelvir-ritonavir) is effective in preventing hospitalization and death from COVID-19, but few people use ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart